ACH - Accendra Health, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ACH

ACCENDRA HEALTH, INC.

NYSE

$1.21

▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$92.67 M

52w High$5.69

52w Low$0.93

Dividend Yield0.02%

FrequencyQuarterly

P/E1.78

Volume678.50K

Shares Out.76.58M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Edward A. Pesicka

COMPENSATION 2026

Salary$1,150,000

Stock Awards$9,560,140

Incentive Plan Pay$345,000

All Other Comp.$102,669

Total$11,157,809

ABOUT

SECTOR

Healthcare

WENT PUBLIC

March 17, 1980

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

6,500

PRICE TARGET

Target High$1.50

Target Low$1.50

Target Median$1.50

Target Consensus$1.50

UPCOMING EARNINGS

DateOct 29, 2026

DayThursday

Rev. Est.$619.39M

OCT

THU

SPLIT RECORD

DATE	TYPE	RATIO
2010-04-01	Forward	3:2
1994-06-09	Forward	3:2
1993-03-23	Forward	3:2
1991-07-17	Forward	3:2
1988-06-01	Forward	3:2
1985-09-03	Forward	3:2
1982-11-01	Forward	2:1
1982-03-15	Forward	11:10
1982-03-11	Forward	11:10
1981-03-06	Forward	11:10

PRICE

$1.21 ▲ UP 0.00% (+$0.00)

OVERLAYS

About Accendra Health, Inc.

https://www.accendrahealth.com ↗

Accendra Health, Inc. is a global healthcare solutions provider offering medical supplies, services to providers, and in-home care products across segments for healthcare providers, manufacturers, and patients.

INDUSTRY

Medical - Distribution

A PRODUCT ACCENDRA HEALTH, INC. IS KNOWN FOR

ResMed AirSense 11 AutoSet CPAP Machine

The ResMed AirSense 11, a sleek CPAP device with humidification and wireless data, supports Accendra Health’s shift to a home-based care focus through its Apria brand, positioning it as a leading sleep apnea therapy solution.

COMPETITORS

COMPETITOR

INSP COMPARE

PHG COMPARE

VVOS COMPARE

Revenue by Products

PRODUCT	Q3-2025	Q4-2025	Q1-2026	Q2-2026
Diabetes Product	$201.37M	$390.94M ▲	$185.79M ▼	$198.82M ▲
Product and Service Other	$72.59M	$143.3M ▲	$57.37M ▼	$47.68M ▼
Wound Care	$48M	$93.69M ▲	$39.4M ▼	$40.19M ▲
Urology	$28.98M	$58.35M ▲	$29.79M ▼	$31.3M ▲